Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):77–83. doi: 10.1097/QAI.0b013e31818d5a27

Table 2. Bivariate and multivariable analysis on predictors of PrEP use intentions (N = 227).

Odds Ratio
(unadjusted)
P-value Odds Ratio
(adjusted)*
P-value
Education
 ≤ Junior high 10.56 0.01 7.70 0.04
 Some high school 3.37 NS 2.46 NS
 High school degree or GED 3.80 NS 2.29 NS
 ≥ College degree 1.00 -- 1.00 --
Annual Income
 <$6K 1.00 -- 1.00 --
 $6K – 11,999 1.15 NS 0.97 NS
 $12K – 17,999 0.95 NS 1.26 NS
 $18K – 23,999 1.78 NS 3.32 NS
 $24K – 29,999 5.67 0.05 13.03 0.04
 $30K – 59,999 0.74 NS 2.02 NS
 >$60K 0.15 0.0005 0.76 NS
Awareness of PrEP 1.00 -- 1.00 --
No awareness of PrEP 2.00 0.05 1.88 NS
No PrEP side effects 2.95 0.006 3.53 0.0013
PrEP side effects 1.00 -- 1.00 --
PrEP does not cost money 3.73 0.02 4.21 0.05
PrEP does cost money 1.00 -- 1.00 --
10 male sex partners in the previous 12-months 2.63 0.002 -- --
> 10 male sex partners in the previous 12-months 1.00 -- -- --
10 anonymous male sex partners in the previous 12-months 2.56 0.007 -- --
> 10 anonymous male sex partners in the previous 12-months 1.00 -- -- --
Not meeting sexual partners on the Internet 2.00 0.03 -- --
Meeting sexual partners on the Internet 1.00 -- -- --
Identifies as a “barebacker” 1.92 0.06 1.39 NS
Does not identify as a “barebacker” 1.00 -- 1.00 --
No previous STI diagnosis 1.81 0.06 1.13 NS
Previous STI diagnosis 1.00 -- 1.00 --
Marijuana use during sex in the previous 12-months 2.18 0.01 1.85 NS
No Marijuana use 1.00 -- 1.00 --
Being less optimistic about HIV management (continuous, higher scores reflecting lower optimism) 0.94 0.05 0.96 NS
*

Final multivariable logistic regression model controlled for age and race/ethnicity.

The following variables were not statistically significant in the bivariate models for PrEP use intention and are not shown in the table: age; race/ethnicity; health care coverage; sexual orientation; depressive symptoms (CES-D); history of nPEP use; alcohol dependence (CAGE questionnaire); substance use during sex in the past 12-months, including poppers, ecstasy, gamma hydroxybutyrate (GHB), cocaine, ketamine, or crystal methamphetamine; unprotected and serodiscordant unprotected anal sex in the past 12-months; total number of male or female sexual partners; number of people participant knows who have HIV; and number of close friends with HIV.

HHS Vulnerability Disclosure